Guadecitabine plus ipilimumab in unresectable melanoma: five-year follow-up and integrated multi-omic analysis in the phase 1b NIBIT-M4 trial
暂无分享，去创建一个
T. Noviello | C. Sautès-Fridman | A. Anichini | R. Mortarini | A. Covre | S. Coral | F. Caruso | M. F. Lofiego | S. Brich | A. D. Di Giacomo | Maria Claudia Costa | Michele Maio | Michele Ceccarelli | Davide Bedognetti | Giovanni Scala | Giancarlo Pruneri | Elena Simonetti | W. Fridman | Rossella Tufano